Earnings Feed
Start Free
Home/Filings/4/0001209191-17-064983
4//SEC Filing

Kafka Steven J. 4

Accession 0001209191-17-064983

CIK 0001488613other
View on SEC.govCompany Profile

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 4:03 PM ET

Size

25.3 KB

Accession

0001209191-17-064983

Insider Transaction Report

Form 4
Period: 2017-12-07
Foundation Medicine, Inc.FMI
Kafka Steven J.
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2017-12-07$61.66/sh−35,156$2,167,719→ 90,987 total
  • Exercise/Conversion

    Common Stock

    2017-12-07$7.12/sh+35,156$250,311→ 126,143 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-12-07−35,156→ 0 total
    Exercise: $7.12Exp: 2023-05-22→ Common Stock (35,156 underlying)
  • Exercise/Conversion

    Common Stock

    2017-12-07$4.16/sh+747$3,108→ 91,734 total
  • Sale

    Common Stock

    2017-12-07$61.66/sh−747$46,060→ 90,987 total
  • Sale

    Common Stock

    2017-12-07$61.66/sh−50,896$3,138,247→ 90,987 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-12-07−747→ 34 total
    Exercise: $4.16Exp: 2023-03-07→ Common Stock (747 underlying)
  • Exercise/Conversion

    Common Stock

    2017-12-07$4.16/sh+1,562$6,498→ 92,549 total
  • Sale

    Common Stock

    2017-12-07$61.66/sh−1,562$96,313→ 90,987 total
  • Exercise/Conversion

    Common Stock

    2017-12-07$4.16/sh+50,896$211,727→ 141,883 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-12-07−1,562→ 0 total
    Exercise: $4.16Exp: 2023-03-07→ Common Stock (1,562 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-12-07−50,896→ 0 total
    Exercise: $4.16Exp: 2023-03-07→ Common Stock (50,896 underlying)
Footnotes (5)
  • [F1]The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.65 to $62.4, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
  • [F2]This is a non-qualified portion of a stock option granted on March 7, 2013 that vested in equal quarterly installments until fully vested on March 7, 2017.
  • [F3]This is a non-qualified stock option that was granted on May 22, 2013 and which vested in equal quarterly installments through May 22, 2017.
  • [F4]This is a stock option granted on March 7, 2013 and which vested in equal quarterly installments until fully vested on March 7, 2017.
  • [F5]This stock option was granted on March 7, 2013 and vested in equal quarterly installments through January 2, 2017.

Documents

1 file

Issuer

Foundation Medicine, Inc.

CIK 0001488613

→
Entity typeother

Related Parties

1
  • filerCIK 0001585005

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 4:03 PM ET
Size
25.3 KB
View on SEC.gov